Back | Next |
home / stock / cris / cris message board
Subject | By | Source | When |
---|---|---|---|
Beautiful close $1.14 up 10.7% HOD ) | subslover | investorshub | 07/08/2022 12:18:02 AM |
Nice day up 10% | subslover | investorshub | 06/18/2022 12:20:44 AM |
Exciting NEWS! Curis Announces Presentations on Biomarker Development | subslover | investorshub | 06/10/2022 9:55:17 PM |
This morning's dip to 0.95 was a great | subslover | investorshub | 06/09/2022 5:06:30 PM |
Closed yesterday @ $1.04 and looking like the | subslover | investorshub | 06/08/2022 10:31:42 AM |
znewcar1: CRIS 20% v11,8M c1.04 f91,6M H1.1 BO.88 to HOD S@1 | znewcar1 | investorshangout | 06/08/2022 3:21:18 AM |
Working on a powerful close! | subslover | investorshub | 06/07/2022 7:20:55 PM |
znewcar1: ML.7 then gap to MH1.145 got S@.84 and has pushed up from there CRIS 20% v7,3M c1.045 f91, | znewcar1 | investorshangout | 06/07/2022 5:22:54 PM |
Excellent trading today. Up almost 15% | subslover | investorshub | 06/07/2022 4:12:56 PM |
Under $1,00 is like taking candy from a baby. | subslover | investorshub | 06/07/2022 11:51:53 AM |
Curis gains over 20% as majority of patients | subslover | investorshub | 06/06/2022 12:59:16 PM |
Yup thats what they did at .96 | Triple nickle | investorshub | 06/03/2022 4:08:52 PM |
Chart tactics Do a double top and pull | Triple nickle | investorshub | 06/03/2022 4:08:06 PM |
Just might fill that gap | Triple nickle | investorshub | 06/03/2022 4:02:45 PM |
Still we dont know where the bottom is. | 4lmaral | investorshub | 05/27/2022 7:58:05 PM |
Depending upon the biotech, they do come back. | conix | investorshub | 04/04/2022 8:08:51 PM |
Looks like two big name brokerage firms may | blue point | investorshub | 09/02/2021 11:57:24 PM |
Cris went from 14 to 7... any pop | Snide Sniper | investorshub | 08/23/2021 5:22:31 PM |
Cris went from 14 to 7... any pop | Snide Sniper | investorshub | 08/23/2021 5:22:30 PM |
Above $10 soon? | Snide Sniper | investorshub | 08/13/2021 1:52:12 PM |
News, Short Squeeze, Breakout and More Instantly...
Curis Announces Additional Data from TakeAim Leukemia Study PR Newswire Data update expands AML dataset from 5 to 30 patients LEXINGTON, Mass. , May 14, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of...
Curis to Present Updated Data from the TakeAim Leukemia Study PR Newswire LEXINGTON, Mass. , May 10, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule ...
Curis Provides First Quarter 2024 Business Update PR Newswire Management to host conference call today at 8:30 a.m. ET LEXINGTON, Mass. , May 7, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of ema...